These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20194707)
1. Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians. Anuurad E; Ozturk Z; Enkhmaa B; Pearson TA; Berglund L J Clin Endocrinol Metab; 2010 May; 95(5):2376-83. PubMed ID: 20194707 [TBL] [Abstract][Full Text] [Related]
2. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk. Gungor Z; Anuurad E; Enkhmaa B; Zhang W; Kim K; Berglund L Atherosclerosis; 2012 Jul; 223(1):230-4. PubMed ID: 22632920 [TBL] [Abstract][Full Text] [Related]
3. Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population. Enkhmaa B; Anuurad E; Zhang W; Pearson TA; Berglund L Atherosclerosis; 2010 Aug; 211(2):526-30. PubMed ID: 20444451 [TBL] [Abstract][Full Text] [Related]
4. Racial variation in lipoprotein-associated phospholipase A₂ in older adults. Lee KK; Fortmann SP; Varady A; Fair JM; Go AS; Quertermous T; Hlatky MA; Iribarren C BMC Cardiovasc Disord; 2011 Jun; 11():38. PubMed ID: 21714927 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study. Kim JY; Hyun YJ; Jang Y; Lee BK; Chae JS; Kim SE; Yeo HY; Jeong TS; Jeon DW; Lee JH Am J Clin Nutr; 2008 Sep; 88(3):630-7. PubMed ID: 18779277 [TBL] [Abstract][Full Text] [Related]
6. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature. Gregson J; Stirnadel-Farrant HA; Doobaree IU; Koro C Atherosclerosis; 2012 Nov; 225(1):11-21. PubMed ID: 22784637 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A(2) bound on high-density lipoprotein is associated with lower risk for cardiac death in stable coronary artery disease patients: a 3-year follow-up. Rallidis LS; Tellis CC; Lekakis J; Rizos I; Varounis C; Charalampopoulos A; Zolindaki M; Dagres N; Anastasiou-Nana M; Tselepis AD J Am Coll Cardiol; 2012 Nov; 60(20):2053-60. PubMed ID: 23083783 [TBL] [Abstract][Full Text] [Related]
8. Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Enkhmaa B; Anuurad E; Ozturk Z; Zhang W; Pearson TA; Berglund L Transl Res; 2011 Aug; 158(2):92-8. PubMed ID: 21757153 [TBL] [Abstract][Full Text] [Related]
9. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Paultre F; Pearson TA; Weil HF; Tuck CH; Myerson M; Rubin J; Francis CK; Marx HF; Philbin EF; Reed RG; Berglund L Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2619-24. PubMed ID: 11116062 [TBL] [Abstract][Full Text] [Related]
10. Elevated plasma lipoprotein-associated phospholipase A₂ activity is associated with plaque rupture in patients with coronary artery disease. Liu CF; Qin L; Ren JY; Chen H; Wang WM; Liu J; Song JX; Li LJ Chin Med J (Engl); 2011 Aug; 124(16):2469-73. PubMed ID: 21933589 [TBL] [Abstract][Full Text] [Related]
11. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. Brilakis ES; Khera A; McGuire DK; See R; Banerjee S; Murphy SA; de Lemos JA Atherosclerosis; 2008 Jul; 199(1):110-5. PubMed ID: 18061193 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. ; Thompson A; Gao P; Orfei L; Watson S; Di Angelantonio E; Kaptoge S; Ballantyne C; Cannon CP; Criqui M; Cushman M; Hofman A; Packard C; Thompson SG; Collins R; Danesh J Lancet; 2010 May; 375(9725):1536-44. PubMed ID: 20435228 [TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death. May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179 [TBL] [Abstract][Full Text] [Related]
15. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Anuurad E; Tracy RP; Pearson TA; Kim K; Berglund L Atherosclerosis; 2009 Jul; 205(1):290-5. PubMed ID: 19135196 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study. Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516 [TBL] [Abstract][Full Text] [Related]
17. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease. Zhang H; Gao Y; Wu D; Zhang D BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193 [TBL] [Abstract][Full Text] [Related]
18. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study. Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235 [TBL] [Abstract][Full Text] [Related]
19. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes. Constantinides A; van Pelt LJ; van Leeuwen JJ; de Vries R; Tio RA; van der Horst IC; Sluiter WJ; Dullaart RP Eur J Clin Invest; 2011 Aug; 41(8):820-7. PubMed ID: 21281278 [TBL] [Abstract][Full Text] [Related]
20. Association of lipoprotein-associated phospholipase A₂ with characteristics of vulnerable coronary atherosclerotic plaques. Liu YS; Hu XB; Li HZ; Jiang WD; Wang X; Lin H; Qin AQ; Wang YM; Zhao T; Dong ZQ; Zhang M; Lu QH Yonsei Med J; 2011 Nov; 52(6):914-22. PubMed ID: 22028154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]